|
CN107522628A
|
|
A kind of L 3（The naphthylamine base of 6 acetyl group 2）The synthetic method of 2 alanines
|
|
CN105001131A
|
|
Synthesizing method for medical intermediate NA-Z-S-benzyl-L-cysteine-4-nitrobenzene thiocyanate
|
|
CN104829695A
|
|
Purifying method for alarelin
|
|
CN104761470A
|
|
Preparation method of (R,S)-2-[[5-(9-fluorenemethoxycarbonylamino)dibenzo[A,D]cycloheptane-2-yl]oxyl]acetic acid
|
|
CN103333088A
|
|
Nalpha-fluorenylmethyloxycarbonyl-Nepsilon-trifluoroacetyl-lysine preparation method
|
|
CN103333087A
|
|
Nalpha-fluorenylmethyloxycarbonyl-Nepsilon- fluorenylmethyloxycarbonyl-lysine preparation method
|
|
CN103145827A
|
|
Solid-phase synthesis method of ularitide
|
|
CN102827258A
|
|
Method for purifying Enfuvirtide
|
|
CN102827055A
|
|
Method for preparing t-butyloxycarboryl-N-4-oxo-proline
|
|
CN102824900A
|
|
Method for chiral separation of various side chain protected amino acids
|
|
CN102775471A
|
|
Method for synthesizing cholecystokinin octapeptide by combining solid phase method and liquid phase method
|
|
CN102775475A
|
|
Method for purifying terlipressin acetate
|
|
CN102718739A
|
|
Method for preparing (2S)-2-[[(9H-fluorene-9-yl methoxy) carbonyl] amino]-3-(2,2-dimethyl-1,3-benzo dioxol-5-yl)propionate
|
|
CN102702327A
|
|
Solid-liquid phase synthesis method for alarelin acetate
|
|
CN102702343A
|
|
Method for synthesizing tesamorelin through solid phases
|
|
CN102702321A
|
|
Method for purifying eptifibatide acetate
|
|
CN102329372A
|
|
Method for preparing peptide aldehyde
|
